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Abstract
A construct (AT1R-NF) containing a “Flag” sequence added to the N-
terminus of the rat AT1 receptor was stably expressed in Chinese
hamster ovary cells and quantified in the cell membrane by confocal
microscopy after reaction with a fluorescein-labeled anti-Flag mono-
clonal antibody. Angiotensin II bound to AT1R-NF and induced
endocytosis with a half-time of 2 min. After 60-90 min, fluorescence
accumulated around the cell nucleus, suggesting migration of the
ligand-receptor complex to the nuclear membrane. Angiotensin an-
tagonists also induced endocytosis, suggesting that a common step in
the transduction signal mechanism occurring after ligand binding may
be responsible for the ligand-receptor complex internalization.
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Introduction
Two receptor subtypes (AT1 and AT2)
have been described for the octapeptide hor-
mone angiotensin II, the AT1 receptor being
responsible for most of the classical actions
of this peptide (for a review, see Ref. 1).
As is the case with other G protein-
coupled receptors, interaction of the AT1
receptor with its specific ligand, besides trig-
gering the release of second messengers that
leads to cellular responses (2), also triggers
endocytosis (for a review, see Ref. 3) and
processing of the ligand-receptor complex
which occurs in endosomes, part of the re-
ceptors being returned to the plasma mem-
brane (4). Internalization and recycling are
important factors in determining the number
of free receptors on the cell surface available
for interaction with the ligand (5).
The structural requirements for ligand-
induced internalization of G protein-coupled
receptors have been investigated, and differ-
ent motifs were found to be involved in this
process. Usually these motifs are located in
the intracellular domains of the receptors
and contain aromatic (mainly tyrosine) or
hydrophobic amino acid residues. One such
motif is the highly conserved NPXXY se-
quence located in the intracellular end of the
seventh transmembrane domain, containing
a tyrosine residue that was shown to be es-
sential for internalization of the ß2-adrener-
gic receptor (6). However, mutations in the
corresponding motif in the angiotensin AT1
receptor did not affect ligand-induced inter-
nalization (7-9). On the other hand, the C-
terminal cytoplasmic domain of AT1 was
1176
Braz J Med Biol Res 34(9) 2001
A.J. Merjan et al.
found to be important for internalization (8,
10,11), particularly residues L316, Y319 (6),
T332, S335, T336 and L337 (7). Further-
more, residues 215-220 at the N-terminal
portion of the third intracellular loop, but not
other segments of this loop, were found to be
important for AT1 endocytosis (12).
Since AT1 ligand-induced internalization
is independent of the triggering of the cellu-
lar responses by angiotensin II, it is possible
that the structural features responsible for
agonist-receptor internalization may differ
from those involved in binding and signal
transduction. In this respect, the available
data are somewhat conflicting. Conchon et
al. (13) report that the agonist [Sar1]-angio-
tensin II and the antagonist [Sar1,Ile8]-angio-
tensin II are equally potent in inducing inter-
nalization of AT1 receptors, whereas the
nonpeptide antagonist DuP735 is far less
potent. Other authors, however, found that
peptide antagonists are much less capable
(14) or incapable (15) of promoting receptor
internalization. These findings, however,
were obtained with radio-iodinated ligands,
and it would be important to compare them
with measurements made with non-iodinated
ligands. Furthermore, previous studies of
internalization were done with the “acid
wash” technique, in which the amount of
internalized radiolabeled ligand is estimated
by the amount of radioactivity that remains
on the cell after treatment with an acidic
solution, which is thought to selectively re-
move non-internalized ligand. It would be
desirable to investigate this phenomenon with
a more direct method for the assessment of
receptor internalization. Therefore, in the
present study we have examined the ability
of non-iodinated agonists and antagonists to
induce internalization of wild-type rat AT1A
receptors stably expressed in Chinese ham-
ster ovary (CHO-K1) cells. To estimate in-
ternalization we used a method based on the
introduction of an epitope (“Flag”) at the
amino terminus of the receptor, and detec-
tion of the Flag-tagged receptor (AT1R-NF)
in the cells by immunofluorescence and con-
focal microscopy.
Material and Methods
Ligands
Angiotensin II, [Sar1]-angiotensin II and
[Sar1,Ala8]-angiotensin II were synthesized
by the solid phase method using Boc-chem-
istry, as previously described (16). The pep-
tides were purified by HPLC and their purity
and molecular weight were confirmed by
mass spectrometry. DuP753 was kindly pro-
vided by the DuPont Merck Pharmaceutical
Co. (Wilmington, DE, USA). Angiotensin II
was labeled in our laboratory with 125I (2200
Ci/mmol) (Amersham, Little Chalfont, Buck-
inghamshire, UK) using the iodo-beads
method (Pierce Chemical Co., Rockford, IL,
USA), as previously described (17).
Construction of pAT1R-NF
A vector coding for a construct containing
the Flag epitope (DYLDDDDL) added to the
N-terminus of the rat AT1A receptor (18) was
generated. Initially, the AT1 cDNA was cut
from the p171 vector (19) by hydrolysis with
the restriction enzymes NcoI and BamHI. The
vector pGEM3z-FlagßH6 (containing the se-
quence: signal peptide-endopeptidase cleav-
age site-Flag-ß-adrenergic receptor) was also
hydrolyzed by the same restriction enzymes to
remove the adrenergic receptor sequence and
the AT1 cDNA was inserted and ligated in its
place. The resulting vector was hydrolyzed
with BamHI and HindIII to release Flag-AT1R
and placed in p171 at the same restriction sites.
The final construct, named pAT1R-NF, con-
tains the AT1 receptor sequence with the addi-
tion of the octapeptide Flag sequence at the N-
terminus.
Transfection of pAT1R-NF into CHO-K1 cells
The cells were seeded at the density of
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104 cells/cm2 in 80-cm2 culture bottles (Corn-
ing Costar Corp., Cambridge, MA, USA)
and maintained in RPMI medium (Gibco
BRL, Gaithersburg, MD, USA) containing
10% fetal calf serum, 2 mM glutamine, 100
U/ml penicillin and 100 µg/ml streptomycin
at 37oC with 5% CO2 and 95% air. After 24 h
the cells were transfected with 20 µg DNA
by co-precipitation with calcium phosphate
(20), and 48 h later were submitted  to antibi-
otic selection with 0.8 mg/ml G-418 (Gibco).
The selection process was maintained for
about 2 weeks, until antibiotic-resistant
clones were obtained. To isolate the clones,
the cells were trypsinized and diluted to a
single cell per well on a 96-well plate. The
cells were maintained under the same condi-
tions and, as confluence was attained, they
were successively transferred to 24- and 6-
well plates.
Northern blot assays
The cells were cultured in 80-cm2 culture
bottles until confluence was reached. Total
RNA was extracted by lysis of the confluent
cells with Trizol solution (Gibco), and puri-
fied under the conditions and according to
the procedures recommended by the manu-
facturer. After electrophoresis on agarose
gel with 1.2% formaldehyde (20), the RNA
was transferred from the gel to a nylon mem-
brane (Bio-Rad Laboratories, Hercules, CA,
USA) by capillarity for 6 h, with saline-
sodium citrate buffer (Sigma, St. Louis, MO,
USA). Hybridization was done at 42oC un-
der the conditions suggested by the mem-
brane manufacturer, using as probes the AT1
receptor cDNA or the region corresponding
to the Flag sequence labeled with 32P-dCTP
(Amersham). The time for autoradiography
varied from 3 to 4 days at -80oC with an
intensifying screen.
Immunocytochemistry
Transfected cells grown on coverslips
were rinsed in 100 mM PBS, pH 7.4, and
then incubated in RPMI medium without
serum (Gibco) at 37oC for 30 min. Ligands
were added to the cells and incubated for
specific time periods in the humidified incu-
bator. The cells were washed twice with 0.5
ml PBS and incubated with 1% BSA in PBS
at 37oC for 30 min to block nonspecific
binding. Two different procedures were used
to visualize the receptors by immunofluores-
cence. To detect the receptors present only
on the cell surface, the ligand-treated cells
were first incubated with 10 µg/ml of pri-
mary antibody (mouse anti-Flag M2 mono-
clonal antibody, Eastman Kodak Co., Roch-
ester, NY, USA) for 30 min at room temper-
ature. The cells were washed with 0.5 ml
PBS and incubated with the secondary anti-
body, rabbit anti-mouse IgG labeled with
fluorescein isothiocyanate (FITC) (Sigma),
and left for 30 min at room temperature. The
coverslips were washed and the cells fixed
with methanol for 3 min and then mounted in
glycerol-buffered PBS (1:9). To reveal intra-
cellularly located receptors as well, the fixa-
tion step preceded the treatment with the
primary and secondary antibodies. Previous
fixation using methanol allowed the anti-
body to reach the intracellular compartment,
a fact that did not occur in the post-fixed
cells. The cells were examined with a Bio-
Rad 1024-UV confocal system attached to a
Zeiss Axiovert 100 microscope, using a 63 x
NA 1.4-Plan-Apochromatic (DIC) oil im-
mersion objective and a 2-mm pinhole.
Kalman averaging was used to collect all
images. The fluorescent images were printed
using an NP-1600 printer from Codonics.
After localizing an area with homogeneously
spread cells, the fluorescence contained on a
defined surface was measured using the
Quant Laser Sharp software, version 1.02
(Bio-Rad). With this program it is possible to
eliminate the background and quantify the
fluorescence emitted by cells. For each ex-
periment, repeated four times, the measure-
ments were made with the same number of
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cells (100). In cells treated with different
ligand concentrations, the rate of internal-
ization was estimated by the disappearance
of the fluorescence associated with the mem-
branes. Groups of cells not treated with the
ligand, in which the fluorescence was re-
stricted to the cell membranes, were used as
controls for internalization.
Receptor internalization
Agonist-induced receptor endocytosis was
estimated by measuring the disappearance of
the AT1R-NF receptor from the cell mem-
brane, as visualized by immunocytochemis-
try, and also by the “acid wash” method, which
is commonly used to distinguish between cell
surface and intracellular receptors (21). The
cells were incubated with 100 nM angiotensin
II for different times and incubations were
stopped by washing with PBS. The cells were
washed for 3 min with 50 mM acetic acid in
150 mM NaCl, pH 3.0, followed by two washes
with PBS. The cells were incubated with BSA,
and then with the primary and secondary anti-
bodies, post-fixed with methanol and exam-
ined for fluorescence as described above.
Binding experiments
CHO-K1 cells transfected with pAT1R-
NF were seeded at 5 x 104 cells per well in
24-well plates, and left for 24 h at 37oC in a
humidified incubator with 5% CO2 and 95%
air. The culture medium was siphoned off
and the cells were washed twice with cold
PBS and then incubated in “binding buffer”
(50 mM Tris-HCl, pH 7.5, 120 mM NaCl, 4
mM KCl, 5 mM MgCl2, 1 mM CaCl2, 10 µg/
ml bacitracin and 2 mg/ml glucose) in the
presence of 30 pM [125I]-angiotensin II and
of different concentrations of unlabeled an-
giotensin II (1 pM to 10 µM). After over-
night incubation at 4oC with gentle shaking,
the binding buffer was siphoned off, the
cells were washed three times with “washing
buffer” (25 mM Tris-HCl, 140 mM NaCl, 5
mM MgCl2, 0.1% BSA) and then lysed with
2% NP-40 solution containing 8 M urea and
3 M acetic acid. Receptor-bound radiolabel
was counted with a gamma counter (Packard)
and the results were treated by nonlinear
regression analysis using the “GraphPad
Prism” (Graph-Pad Software, San Diego,
CA, USA) to determine the kinetic constants.
Results
Characterization of the AT1R-NF receptor
expressed in CHO-K1 cells
The expression of the AT1 receptor, alone
or linked with the Flag epitope, was ana-
lyzed by Northern blot using total RNA
extracted from stably transfected CHO-K1
cells. Figure 1 shows that the untransfected
cells expressed undetectable levels of AT1
receptor mRNA, whereas those transfected
with AT1R-NF showed a positive signal with
both probes of a size corresponding to about
18S ribosomal RNA. When a 32P-labeled
oligonucleotide complementary to the Flag
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Figure 1. Northern blot of total
RNA extracted from CHO-K1
cells. Lanes 1 and 4, Nontrans-
fected cells; lanes 2 and 5, cells
transfected with AT1R-NF; lanes
3 and 6, cells transfected with
the wild-type receptor. Blots
were probed with a 32P-labeled
oligonucleotide complementary
to the Flag sequence (lanes 1, 2
and 3) or with full-length wild-
type cDNA (lanes 4, 5 and 6).
The positions of 28S and 18S
ribosomal RNA are indicated.
Figure 2. Competition binding of
angiotensin II to CHO-K1 cells
stably expressing AT1R-NF and
wild-type receptors. The cells
were incubated overnight with
30 pM [125I]-angiotensin II ([125I]-
Ang II) at 4oC in the presence of
different concentrations of unla-
beled angiotensin II. Each point
represents the mean ± SD from
6-9 determinations.
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sequence was used as a probe, only cells
transfected with AT1R-NF showed the cor-
responding band, confirming the presence of
the Flag label in the receptor.
Figure 2 shows that the ligand-binding
properties of the CHO-K1 cells expressing
the Flag-labeled receptor were similar to
those of the wild-type AT1, with EC50 values
of 6.2 nM and 5.8 nM, respectively.
Immunocytochemistry
In cells expressing the AT1R-NF mutant,
strong fluorescence signals were observed
after treatment with 100 nM angiotensin II
and incubation with the anti-Flag antibody at
room temperature. When incubation with
the antibody preceded fixation, a strong flu-
orescence was observed on the cell surface
(Figure 3A), which gradually disappeared at
37oC (Figure 3B-D). When incubation was
performed at 4oC, the fluorescence remained
on the cell surface after 90 min (Figure 3E).
When the antibody was applied to angio-
tensin II-treated cells after fixation with
methanol, the fluorescence initially appeared
on the cell surface (Figure 4A), and then
gradually moved to the intracellular space
(Figure 4B-F). At the end of the 90-min
observation period, all fluorescence had dis-
appeared from the cell surface and tended to
be distributed around the cell nuclei (Figure
4F). In nontransformed CHO cells and in
cells transfected with wild-type AT1 recep-
tors no fluorescence was observed after up
to 90-min incubation using either protocol
(data not shown).
A half-time of internalization of 2 min
was found, which was confirmed by the acid
Figure 3. Agonist-induced AT1R-NF internalization visu-
alized by reaction with the anti-Flag M2 antibody before
fixation with methanol. CHO-K1 cells expressing the
AT1R-NF receptor were incubated with 100 nM angio-
tensin II at 37oC for 0 (A), 10 (B), 30 (C) and 90 (D) min
or at 4oC for 24 h (E). The cells’ immunofluorescence is
shown on the left and the respective no-mask images
are shown on the right.
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Figure 4. Agonist-induced AT1R-NF internalization visualized by reaction with the anti-Flag M2 antibody after
fixation with methanol. CHO-K1 cells expressing the AT1R-NF receptor were incubated with 100 nM angiotensin II
at 37oC for 0 (A), 10 (B), 20 (C), 40 (D), 60 (E) and 90 (F) min.
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wash method (data not shown) and was simi-
lar to the values described in the literature
for angiotensin endocytosis in different cells
(21). Figure 5 shows that angiotensin II in-
duced internalization of the AT1R-NF re-
ceptor with an EC50 of 2 nM, which is close
to the 6.2 nM value obtained in the binding
experiments (Figure 2). Similar results were
obtained with other ligands, namely the ago-
nistic peptide analogue [Sar1]-angiotensin II
and the antagonistic peptide analogue
[Sar1,Ala8]-angiotensin II, whereas the non-
peptide antagonist DuP753 was internalized
with about 50% of the degree of endocytosis
observed with angiotensin II. As a control
we employed bradykinin, a peptide that does
not interact with angiotensin II receptors and
was not internalized.
Staurosporine, an inhibitor of protein ki-
nases C and A, which is thought to inhibit
receptor desensitization (22), had no signifi-
cant effect on the internalization induced by
high angiotensin II concentrations (Figure 5).
Discussion
Our results show that CHO-K1 cells sta-
bly transfected with the Flag-tagged angio-
tensin II receptor bind angiotensin II with an
affinity similar to that of cells expressing the
wild-type AT1, confirming that the modified
receptor is properly expressed in the cell
membrane (3).
We have demonstrated that the expres-
sion of the AT1R-NF receptor in the cell
membrane may be quantitatively determined
by integration of the fluorescence signal as-
sociated with the membrane after treatment
with the mouse anti-Flag antibody followed
by the fluorescent-labeled rabbit anti-mouse
IgG. This quantitation of the receptors pres-
ent on the cell membrane allows a more
direct procedure to measure angiotensin II
receptor endocytosis. The internalization was
specific for AT1 receptor ligands, since it
was not observed with bradykinin, which
does not bind to angiotensin II receptors. In
addition, the protein kinase inhibitor stauro-
sporine did not prevent internalization, in
agreement with the hypothesis that desensi-
tization is caused by the rapid uncoupling of
the receptor from G protein and not neces-
sarily by receptor internalization (22,23).
Although less is known about the sites of
the extracellular domains of AT1 that are
important for triggering receptor internaliza-
tion, some information may be inferred from
ligand structure-activity studies. The pep-
tide analogue [Sar1]-angiotensin II, which
has a high agonistic activity (24), and the
peptide antagonist [Sar1,Ala8]-angiotensin II
both caused internalization with the same
efficiency as angiotensin II (Figure 5). This
is in agreement with the previous finding
that [Sar1]-angiotensin II and [Sar1,Ile8]-an-
giotensin II are equally capable of promoting
receptor internalization in CHO cells ex-
pressing AT1 (13), but contrasts with reports
that angiotensin II antagonists are less ca-
pable (14) or incapable (25) to induce en-
docytosis in cultured adrenal glomerulosa
cells.
It is noteworthy that even the nonpeptide
antagonist DuP753 was able to induce en-
docytosis, albeit with less efficiency than the
peptide analogues, also in agreement with
previous findings with transfected CHO cells
(14). Since previous work has shown that
different receptor sites are responsible for
binding peptide and nonpeptide ligands
Figure 5. Effect of different
ligands on the rate of angio-
tensin II (Ang II) receptor inter-
nalization. The CHO-K1 cells ex-
pressing the AT1R-NF receptor
were incubated with different
concentrations of the ligands at
37oC for 30 min and fixed with
methanol after labeling with the
anti-Flag/FITC-anti-mouse IgG
system. The fluorescence signal
associated with the cell mem-
brane was integrated and ex-
pressed as a percentage of the
fluorescence emitted by cells in-
cubated in the absence of ligand.
-12 -11 -10 -9 -8 -7
log [ligand] (M)
[Sar1,Ala8]-Ang II
[Sar1]-Ang II
Staurosporine + Ang II
Bradykinin
DuP753
Ang II
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(26,27), the fact that both types of ligands
cause internalization suggests that a com-
mon step in the transduction chain of events
occurring after binding may be responsible
for ligand-induced endocytosis. Further stud-
ies are needed to investigate this possibility
and to characterize this hypothetical step.
Receptor-mediated sequestration and en-
docytosis have been shown to be the first
steps in receptor processing and recycling,
involving capture of both ligand and recep-
tor by endosomes, followed by diversion of
angiotensin II to lysosomes and recycling of
the receptors to the plasma membrane (4). In
our experiments, however, we detected an
accumulation of immunofluorescence around
the cell nuclei, indicating that part of the
receptor molecules are able to reach the
nucleus, possibly bound to their specific
ligand.
Some evidence has been reported that
angiotensin II, besides its better known ef-
fect on plasma membrane receptors trigger-
ing second-messenger cascades, may be
transported to the nucleus, where it may
interact directly with receptors on the nuclear
membrane. Thus, early autoradiographic ex-
periments (28) showed that tritium-labeled
angiotensin II accumulated around the nu-
clei of smooth and cardiac muscle cells, and
more recent work showed that an angio-
tensin II-colloidal gold conjugate also tended
to locate around the nuclei (29). Further-
more, high-affinity specific angiotensin II
receptors of type I were shown to be present
in the nuclear membrane and to induce tran-
scription of renin and angiotensinogen RNA
(30,31).
A high-affinity soluble angiotensin II-
binding protein has been described in the
cytosol of liver cells (32), which may play a
role in transporting angiotensin II molecules
from the cell membrane to the perinuclear
space where it may interact with nuclear
membrane receptors. Another possibility,
however, suggested by our results, is that the
AT1 receptor itself, through ligand-induced
internalization, may transport the hormone
to the nucleus, where it might deliver it to the
nuclear receptors.
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